Fleming Harold Edward has filed 6 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 19959 shares of Sionna Therapeutics, Inc. ($SION) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Sionna Therapeutics, Inc. | $SION | Fleming Harold Edward | Director | A | Non-Qualified Stock Option (right to buy) | 19959 | $0.00 | 19,959.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | Upstream Bio, Inc. | $UPB | Fleming Harold Edward | Not found | A | Stock Option (Right to Buy) | 17096 | $0.00 | 17,096.0000 | 53,640,895 | 9999.99% | 0.03% |
| June 5, 2025 | CRISPR Therapeutics AG | $CRSP | Fleming Harold Edward | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 85,774,474 | 9999.99% | 0.02% |
| Oct. 10, 2024 | Upstream Bio, Inc. | $UPB | Fleming Harold Edward | Not found | A | Stock Option (Right to Buy) | 17096 | $0.00 | 17,096.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | CRISPR Therapeutics AG | $CRSP | Fleming Harold Edward | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | CRISPR Therapeutics AG | $CRSP | Fleming Harold Edward | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |